Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAFT-P&A RCT: Pharmacological Rate Control vs. Pace and Ablate in AF and HF
NCT06299514Recruiting
- Start
- Apr 2024
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib) and heart failure (HF) (2 arms). Primary endpoint: Win Ratio at 12 months. Started Apr 2024; status: recruiting.
02
Conditions
Atrial fibrillation (AFib)heart failure (HF)
Beyond the preview
Go deeper on NCT06299514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06299514.